# Kyntra Bio, Inc.: filings

KYNB · Nasdaq · CIK 921299 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kynb.md) · [Financials](/companies/kynb/financials.md) · [Filings](/companies/kynb/filings.md) · [Insiders](/companies/kynb/insiders.md)

## Reports and events: 246 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 709, 8-K 178, SC 13G/A 41, 10-Q 35, 3 31, 144 18, CT ORDER 18, DEFA14A 13, 10-K 12, DEF 14A 12, UPLOAD 12, CORRESP 11, SC 13G 10, 4/A 9, SCHEDULE 13G/A 9, S-8 8, 424B5 5, 5 5, ARS 5, S-1/A 5, 3/A 4, DRS/A 3, S-3ASR 3, DRSLTR 2, EFFECT 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, 424B4 1, 5/A 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, D 1, DRS 1, PRE 14A 1, S-1 1, S-1MEF 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 20:05 ET | [8-K](/filings/0001193125-26-415545.md) | 3.01 Delisting notice | 0001193125-26-415545 |
| 2026-10-01 | 11:30 ET | [8-K](/filings/0001193125-26-409819.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-409819 |
| 2026-08-31 | 21:18 ET | [8-K](/filings/0001193125-26-377059.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-377059 |
| 2026-08-13 | 20:10 ET | [10-Q](/filings/0001193125-26-349183.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349183 |
| 2026-08-13 | 20:05 ET | [8-K](/filings/0001193125-26-349141.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349141 |
| 2026-06-16 | 23:23 ET | [8-K](/filings/0001193125-26-271449.md) | 5.07 Shareholder vote results | 0001193125-26-271449 |
| 2026-06-09 | 21:04 ET | [8-K](/filings/0001193125-26-264000.md) | 8.01 Other events | 0001193125-26-264000 |
| 2026-05-12 | 20:05 ET | [10-Q](/filings/0001193125-26-219374.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219374 |
| 2026-05-11 | 20:05 ET | [8-K](/filings/0001193125-26-216731.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216731 |
| 2026-04-27 | 20:06 ET | [DEF 14A](/filings/0001193125-26-182044.md) | Proxy statement, period 2026-06-12 | 0001193125-26-182044 |
| 2026-04-09 | 20:10 ET | [8-K](/filings/0001193125-26-149624.md) | 3.01 Delisting notice | 0001193125-26-149624 |
| 2026-03-16 | 20:10 ET | [10-K](/filings/0001193125-26-108346.md) | Annual report, period 2025-12-31 | 0001193125-26-108346 |
| 2026-03-16 | 20:05 ET | [8-K](/filings/0001193125-26-108324.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-108324 |
| 2026-01-07 | 21:15 ET | [8-K](/filings/0001193125-26-006327.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-006327 |
| 2025-11-10 | 21:11 ET | [10-Q](/filings/0001193125-25-274241.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274241 |
| 2025-11-10 | 21:05 ET | [8-K](/filings/0001193125-25-274192.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274192 |
| 2025-11-06 | 21:11 ET | [8-K](/filings/0001193125-25-269529.md) | 8.01 Other events | 0001193125-25-269529 |
| 2025-09-05 | 21:04 ET | [8-K](/filings/0000921299-25-000007.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000921299-25-000007 |
| 2025-09-02 | 12:00 ET | [8-K](/filings/0000950170-25-112341.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112341 |
| 2025-08-18 | 12:45 ET | [8-K](/filings/0000950170-25-109571.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-109571 |
| 2025-08-14 | 23:53 ET | [8-K](/filings/0000950170-25-108280.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-108280 |
| 2025-08-11 | 20:10 ET | [10-Q](/filings/0000950170-25-106549.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106549 |
| 2025-08-11 | 20:05 ET | [8-K](/filings/0000950170-25-106534.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106534 |
| 2025-07-14 | 21:08 ET | [8-K](/filings/0000950170-25-095628.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-095628 |
| 2025-06-13 | 20:05 ET | [8-K](/filings/0000950170-25-086142.md) | 1.02 Termination of a material agreement | 0000950170-25-086142 |
| 2025-06-12 | 20:27 ET | [8-K](/filings/0000950170-25-085439.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-085439 |
| 2025-06-09 | 20:00 ET | [8-K](/filings/0000950170-25-083676.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-083676 |
| 2025-05-12 | 20:10 ET | [10-Q](/filings/0000950170-25-069203.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069203 |
| 2025-05-12 | 20:05 ET | [8-K](/filings/0000950170-25-069159.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069159 |
| 2025-04-25 | 21:00 ET | [DEF 14A](/filings/0000950170-25-058841.md) | Proxy statement, period 2025-06-04 | 0000950170-25-058841 |
| 2025-04-04 | 21:00 ET | [8-K](/filings/0000950170-25-051219.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-051219 |
| 2025-03-31 | 21:44 ET | [8-K](/filings/0000950170-25-046978.md) | 7.01 Regulation FD disclosure | 0000950170-25-046978 |
| 2025-03-28 | 21:20 ET | [8-K](/filings/0000950170-25-046948.md) | 1.01 Entry into a material agreement | 0000950170-25-046948 |
| 2025-03-17 | 20:15 ET | [10-K](/filings/0000950170-25-040280.md) | Annual report, period 2024-12-31 | 0000950170-25-040280 |
| 2025-03-17 | 20:10 ET | [8-K](/filings/0000950170-25-040248.md) | 2.02 Results of operations; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-040248 |
| 2025-02-24 | 22:22 ET | [8-K](/filings/0001193125-25-033539.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-033539 |
| 2025-02-20 | 12:00 ET | [8-K](/filings/0000950170-25-023729.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-023729 |
| 2024-12-16 | 14:15 ET | [8-K](/filings/0000950170-24-136408.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-136408 |
| 2024-11-12 | 21:10 ET | [10-Q](/filings/0000950170-24-125388.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125388 |
| 2024-11-12 | 21:05 ET | [8-K](/filings/0000950170-24-125332.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125332 |
| 2024-10-03 | 20:05 ET | [8-K](/filings/0000950170-24-112331.md) | 1.02 Termination of a material agreement | 0000950170-24-112331 |
| 2024-09-16 | 20:05 ET | [8-K](/filings/0000950170-24-106818.md) | 3.01 Delisting notice | 0000950170-24-106818 |
| 2024-09-13 | 20:12 ET | [8-K](/filings/0000950170-24-106359.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-106359 |
| 2024-09-06 | 20:11 ET | [8-K](/filings/0000950170-24-104395.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-104395 |
| 2024-08-07 | 21:05 ET | [8-K](/filings/0000950170-24-092967.md) | 2.05 Exit or disposal costs | 0000950170-24-092967 |
| 2024-08-06 | 20:11 ET | [10-Q](/filings/0000950170-24-091808.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091808 |
| 2024-08-06 | 20:05 ET | [8-K](/filings/0000950170-24-091766.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091766 |
| 2024-06-26 | 12:00 ET | [8-K](/filings/0000950170-24-077616.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-077616 |
| 2024-06-07 | 20:12 ET | [8-K](/filings/0000950170-24-070636.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-070636 |
| 2024-05-06 | 20:10 ET | [10-Q](/filings/0000950170-24-053554.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053554 |

Page 1 of 5. [Older](/companies/kynb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.